| # | Drug | Count |
|---|---|---|
| 0 | TACROLIMUS | 13 |
| 1 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 11 |
| 2 | TACROLIMUS OINTMENT 0.1% | 11 |
| 3 | DICLOFENAC | 10 |
| 4 | DICLOFENAC SODIUM | 10 |
| 5 | ASPIRIN | 8 |
| 6 | ASPIRIN 325 MG | 8 |
| 7 | ASPIRIN 81 MG | 8 |
| 8 | AZATHIOPRINE | 7 |
| 9 | MYCOPHENOLATE MOFETIL | 2 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | COLESEVELAM HYDROCHLORIDE | 1 | 0.0009 |
| 1 | MARIBAVIR | 1 | 0.0004 |
| 2 | TACROLIMUS OINTMENT 0.1% | 11 | 0.0001 |
| 3 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 11 | 0.0001 |
| 4 | TACROLIMUS | 13 | 0.0001 |
| 5 | AZATHIOPRINE | 7 | 0.0001 |
| 6 | TEDUGLUTIDE | 1 | 0.0001 |
| 7 | SIROLIMUS | 1 | 0.0001 |
| 8 | DICLOFENAC SODIUM | 10 | 0.0001 |
| 9 | VALGANCICLOVIR | 1 | 0.0001 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Cytomegalovirus pUL97 Kinase Inhibitor [EPC] | 1 | 0.0004 |
| 1 | GLP-2 Analog [EPC] | 1 | 0.0001 |
| 2 | Purine Antimetabolite [EPC] | 7 | 0.0001 |
| 3 | Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] | 1 | 0.0000 |
| 4 | Platelet Aggregation Inhibitor [EPC] | 8 | 0.0000 |
| 5 | Dihydrofolate Reductase Inhibitor Antibacterial [EPC] | 1 | 0.0000 |
| 6 | Nonsteroidal Anti-inflammatory Drug [EPC] | 10 | 0.0000 |
| 7 | Vascular Endothelial Growth Factor Inhibitor [EPC] | 1 | 0.0000 |
| 8 | CD20-directed Cytolytic Antibody [EPC] | 1 | 0.0000 |
| 9 | Angiotensin 2 Receptor Blocker [EPC] | 1 | 0.0000 |